Zarkin GA, Bala MV, Calingaert B, VanderLugt JT. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm. Am J Manag Care. 1997 Jan 1;3(9):1387-94.
Neighbors D. Pharmacoeconomic endpoints in FUMA3007: a randomized, open-label study comparing a 28-day oral regimen of 5-fluorouracil plus 776c85 to intravenous gemcitabine for the first-line treatment of patients with unresectable advanced adenocarcinoma of the pancreas. Presented at the Investigator Meeting; 1997. Atlanta, GA.